Showing results (31-40 of 378) with videos related to

Sort By:
Pageof 38
Journal of Biopharmaceutical Statistics|September 7, 2017
Definitions and statistical properties of master protocols for personalized medicine in oncologyLindsay A Renfro, Sumithra J Mandrekar
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2009
Biostatistics: a toolkit for exploration, validation, and interpretation of clinical dataJayawant N Mandrekar, Sumithra J Mandrekar
NEJM Evidence|February 6, 2024
Strategies to Account for Design Misspecifications in Randomized Controlled TrialsAmy S Ruppert, Sumithra J Mandrekar
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2017
Keyboard: A Novel Bayesian Toxicity Probability Interval Design for Phase I Clinical TrialsFangrong Yan, Sumithra J Mandrekar, Ying Yuan
Chinese Clinical Oncology|September 27, 2015
Molecular and clinical implementations of ovarian cancer mouse avatar modelsAmira A Zayed, Sumithra J Mandrekar, Paul Haluska
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Improving Clinical Trial Efficiency: Thinking outside the BoxSumithra J Mandrekar, Suzanne E Dahlberg, Richard Simon
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 2, 2011
Comparison of continuous versus categorical tumor measurement-based metrics to predict overall survival in cancer treatment trialsMing-Wen An, Sumithra J Mandrekar, Megan E Branda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2013
Missing data and measurement variability in assessing progression-free survival endpoint in randomized clinical trialsRajeshwari Sridhara, Sumithra J Mandrekar, Lori E Dodd
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 1, 2021
Statistical Models in Clinical StudiesShigeyuki Matsui, Jennifer Le-Rademacher, Sumithra J Mandrekar
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Evaluation of the value of attribution in the interpretation of adverse event data: a North Central Cancer Treatment Group and American College of Surgeons Oncology Group investigationShauna L Hillman, Sumithra J Mandrekar, Brian Bot, et al.
Pageof 38